AstraZeneca CEO on immunotherapy, drug prices

Pascal Soriot, AstraZeneca CEO, speaks to CNBC's Meg Tirrell at American Society of Clinical Oncology (ASCO) conference about the company's immunotherapy treatments, research and development and his thoughts on drug pricing.
05:27
Mon, Jun 4 201811:27 AM EST